ESR1 and neoplasm: Also, when tested against all variables, the EDI-high group was found to be enriched with samples that are large in tumor size (>5 cm), lymph node positive, or ER negative, but not with any PAM50 or IntClust subtypes (p < 0.05, Fisher’s exact test; Figs 3C and S7).